Inflammatory stromal cells in the myeloma microenvironment

Nat Immunol. 2021 Jun;22(6):677-678. doi: 10.1038/s41590-021-00947-9.

Romanos Sklavenitis-Pistofidis^#^{1

2

3}, Nicholas J Haradhvala^#^{3

4}, Gad Getz^{3

5}, Irene M Ghobrial^{6

7

8}

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
² Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, USA.
³ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁴ Harvard Graduate Program in Biophysics, Harvard University, Cambridge, MA, USA.
⁵ Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁶ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.
⁷ Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.
⁸ Broad Institute of MIT and Harvard, Cambridge, MA, USA. irene_ghobrial@dfci.harvard.edu.

^# Contributed equally.

No abstract available

Publication types